Interventional Cardiology Devices Market Research Highlights Recent Developments and Strategic Initiatives

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Interventional Cardiology Devices Market- (By Product (Angioplasty Balloons (Old/Normal Balloons, Drug-eluting Balloons, Cutting and Scoring Balloons), Angioplasty Stents (Drug-eluting Stents, Bare-metal Stents, Bioabsorbable Stents), Structural Heart Devics (Aortic Valve Therapy Devices, Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)), Catheters (Angiography Catheters, Guiding Catheters, IVUS/OCT Catheters), Plaque Modification Devices (Atherectomy Devices, Thrombectomy Devices), Hemodynamic Flow Alteration Devices (Embolic Protection Devices, Chronic Total Occlusion Devices), Other Devices (Guidewires, Vascular Closure Devices, Introducer Sheaths, Hemostasis Valves, Balloon Inflation Devices)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

The Interventional Cardiology Devices Market Size is valued at USD 18.84 Bn in 2023 and is predicted to reach USD 33.91 Bn by the year 2031 at a 7.75% CAGR during the forecast period for 2024-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2012

Interventional cardiology devices are sophisticated medical tools used to diagnose and treat cardiovascular disorders through minimally invasive, catheter-based procedures. These devices are central to modern interventional cardiology, offering effective alternatives to conventional open-heart surgeries and enabling more precise and efficient patient management.

Current global health data indicate that heart attacks and strokes account for more than 80% of cardiovascular-related deaths, with a significant share occurring in individuals below 70 years of age. Behavioral risk factors-including poor dietary habits, tobacco consumption, physical inactivity, and excessive alcohol use-remain primary contributors to the global rise in cardiovascular disease. Furthermore, the increasing prevalence of obesity and hypertension, both strongly associated with elevated cardiovascular risk, is expected to support consistent demand for interventional cardiology solutions.

The market is additionally strengthened by the growing incidence of chronic diseases such as diabetes and hypertension, which significantly amplify the risk of cardiovascular complications. Diabetes, in particular, can impair vascular health due to prolonged elevated blood glucose levels, thereby increasing the likelihood of coronary artery disease. Consequently, the demand for interventional cardiology devices is projected to rise steadily over the forecast period, driven by the expanding prevalence of these risk factors and the heightened focus on early diagnosis and minimally invasive therapeutic approaches.

List of Prominent Players in the Interventional Cardiology Devices Market:
• Medtronic (US),
• Boston Scientific Corporation (US),
• Abbott (US),
• Edward Lifescinces Corporation (US),
• Cardinal Health (US),
• iVascular (Spain),
• Becton, Dickinson, and Company (US),
• B. Braun Melsungen (Germany),
• Terumo Corporation (Japan),
• Biosensors International Group (Singapore),
• BIOTRONIK SE & Co. KG (Germany).

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics
Drivers:
Cardiovascular conditions, including valvular abnormalities and atrial stenosis, are highly prevalent in emerging economies such as China, India, and Brazil, creating substantial demand for interventional cardiology devices. In response, major medical device manufacturers are increasing investments in research and development to introduce advanced, market-specific innovations. Additionally, industry leaders are forming strategic partnerships to conduct clinical trials aimed at validating and enhancing the performance of interventional devices. Market growth is further supported by the rising number of regulatory approvals in developing countries, particularly for products manufactured by domestic companies.

Challenges:
The interventional cardiology device market faced considerable disruption in 2020 due to the COVID-19 pandemic, which resulted in the widespread deferral of elective procedures. Healthcare systems worldwide shifted their resources toward managing COVID-19 cases, causing delays in the diagnosis and treatment of structural and coronary heart diseases. However, by 2021, the reinstatement of elective and interventional procedures-especially coronary interventions-accelerated across several regions. The post-pandemic preference for minimally invasive treatment options, driven by enhanced infection control priorities, continues to support market recovery and future growth.

Regional Trends:
North America is projected to retain the largest share of the interventional cardiology device market, supported by the high incidence of coronary artery disease and strong industry emphasis on developing next-generation technologies. Increased diagnostic rates and the widespread adoption of interventional treatments further contribute to regional market expansion. Europe also captured a notable share of the market in 2021, bolstered by broad access to interventional cardiology devices and favorable cost structures across several countries.

Recent Developments:
• In Feb 2023, Abbott agreed to buy Cardiovascular Systems (CSI), a business that makes medical devices, in a deal worth about $890 Bn. Interventional treatment devices for people with peripheral and coronary artery disease were made by CSI and sold to patients. The devices were made for atherectomy, which is a minimally invasive way to treat plaque buildup in the vessels that can stop blood flow.
• In March 2021, The multinational medical technology company Medtronic recently declared the commercialization of their Chameleon Percutaneous Transluminal Angioplasty (PTA) balloon catheter in various nations, including Italy, Portugal, South Africa, and Turkey. The gadget facilitates the administration of diagnostic or therapeutic fluids by means of the integrated injection port located near the balloon.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2012

Segmentation of Interventional Cardiology Devices Market-
By Product
• Angioplasty Balloons
o Old/Normal Balloons
o Drug-eluting Balloons
o Cutting and Scoring Balloons
• Angioplasty Stents
o Drug-eluting Stents
o Bare-metal Stents
o Bioabsorbable Stents
• Structural Heart Devics
o Aortic Valve Therapy Devices
o Other Therapy Devices (Mitral valve, pulmonary valve and tricuspid valve and left atrial appendage therapy devices)
• Catheters
o Angiography Catheters
o Guiding Catheters
o IVUS/OCT Catheters
• Plaque Modification Devices
o Atherectomy Devices
o Thrombectomy Devices
• Hemodynamic Flow Alteration Devices
o Embolic Protection Devices
o Chronic Total Occlusion Devices
• Other Devices
o Guidewires
o Vascular Closure Devices
o Introducer Sheaths
o Hemostasis Valves
o Balloon Inflation Devices
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Read Overview Report- https://www.insightaceanalytic.com/report/interventional-cardiology-devices-market/2012

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.